Skip to content

    Hepatitis Health Center

    Font Size
    A
    A
    A

    Hepatitis C Achilles Heel Found

    Drugs Now In Pipeline May Shorten, Ease Hepatitis C Treatment
    By
    WebMD Health News

    April 17, 2003 -- The central mystery of hepatitis C now is solved. A new finding promises more effective, shorter, and easier hepatitis C treatments.

    What Michael Gale Jr., PhD, and colleagues discovered is how hepatitis C virus establishes lifelong infection. They found that the virus makes a key that lets it turn off a cell's anti-virus machinery. And they found that a type of drug -- already in development by several companies -- robs the virus of this key. Without it, the anti-viral machinery comes to life. It churns out a chemical called interferon that rids the cell of the hepatitis C virus.

    "The beauty of [this type of drug] is it can clear persistently infected cells," Gale tells WebMD. "The cells rid themselves of hepatitis C virus within an average time of four to five days."

    Gale and colleagues at University of Texas Southwestern Medical Center, Dallas, wondered why hepatitis C virus is able to cause long-lasting infection. Most viruses can't do that. Gale guessed that hepatitis C virus must somehow disable a crucial immune response -- some part of the innate immune system that's part of almost every cell in the body.

    A crucial clue came from the McGill University lab of John Hiscott, PhD, in Montreal. Hiscott was studying the molecular switches that trigger interferon release inside a cell. One of these triggers is called interferon regulatory factor 3 or IRF-3. He gave Gale some IRF-3 to work with.

    Gale's lab then found that a protein made by hepatitis C virus blocks IRF-3.

    "By blocking it completely, hepatitis C virus prevents the cell from mounting an immune response," Gale says. "That lets the virus get a foothold soon after infection. Once it has this foothold, it never lets go."

    The IRF-3 blocking protein is an enzyme called protease. Like hepatitis C virus, the AIDS virus also makes a kind of protease. Drugs that disable protease -- protease inhibitors -- revolutionized AIDS treatment. Several inhibitors of hepatitis C protease are now in the drug pipeline. Schering-Plough Corp. gave Gale some of its experimental drug, which he calls SCH6.

    Today on WebMD

    Hepatitus C virus
    Types, symptoms and treatments.
    liver illustration
    Myths and facts about this essential organ.
     
    woman eating apple
    What you need to know.
    doctor and patient
    What causes it?
     
    Hepatitis C Treatment
    Article
    Syringes and graph illustration
    Tool
     
    liver illustration
    Quiz
    passport, pills and vaccine
    Slideshow
     
    Scientist looking in microscope
    Slideshow
    Fatty Liver Disease
    Article
     
    Digestive Diseases Liver Transplantation
    Article
    Picture Of The Liver
    Image Collection